Superparamagnetic iron oxide (SPIO) for axillary mapping in patients with ductal carcinoma in situ undergoing mastectomy: single-institution experience
JK Addae, RS Sweeting, IM Meszoely… - Breast Cancer Research …, 2024 - Springer
Purpose Unnecessary axillary surgery can potentially be avoided in patients with DCIS
undergoing mastectomy. Current guidelines recommend upfront sentinel lymph node biopsy …
undergoing mastectomy. Current guidelines recommend upfront sentinel lymph node biopsy …
[HTML][HTML] Cost containment analysis of superparamagnetic iron oxide (SPIO) injection in patients with ductal carcinoma in situ
O Solís, J Addae, R Sweeting, I Meszoely… - Breast Cancer Research …, 2024 - Springer
Purpose Recent studies have established the safety and efficacy of Superparamagnetic Iron
Oxide (SPIO, Magtrace®) for delayed sentinel lymph node biopsy (SLNB) in patients with …
Oxide (SPIO, Magtrace®) for delayed sentinel lymph node biopsy (SLNB) in patients with …
Effect of preoperative injection of superparamagnetic iron oxide particles on rates of sentinel lymph node dissection in women undergoing surgery for ductal …
A Karakatsanis, AF Hersi, L Pistiolis… - Journal of British …, 2019 - academic.oup.com
Background One-fifth of patients with a preoperative diagnosis of ductal carcinoma in situ
(DCIS) have invasive breast cancer (IBC) on definitive histology. Sentinel lymph node …
(DCIS) have invasive breast cancer (IBC) on definitive histology. Sentinel lymph node …
Magnetic lymphatic tracing for omission of sentinel lymph node biopsies in mastectomy patients: a community cancer center experience
M Samaha, A Fellner, K Raque, A Kuritzky… - Breast Cancer Research …, 2024 - Springer
Background Patients with ductal carcinoma in situ (DCIS) and patients undergoing risk
reduction mastectomy may undergo sentinel lymph node biopsy (SLNB) at the time of …
reduction mastectomy may undergo sentinel lymph node biopsy (SLNB) at the time of …
[HTML][HTML] Delayed sentinel lymph node dissection in patients with a preoperative diagnosis of ductal cancer in situ by preoperative injection with superparamagnetic …
A Karakatsanis, S Eriksson, L Pistiolis… - Annals of Surgical …, 2023 - Springer
Background Difficulty in preoperatively assessing the risk for occult invasion or surgery that
precludes future accurate axillary mapping in patients with ductal cancer in situ (DCIS) …
precludes future accurate axillary mapping in patients with ductal cancer in situ (DCIS) …
Clinical Longevity of Preoperative Injection of Superparamagnetic Iron Oxide Nanoparticles for Delayed Sentinel Lymph Node Biopsy
G Muanamputu, BK Sparkman… - The American …, 2024 - journals.sagepub.com
Diagnosis of ductal carcinoma in situ (DCIS) represents about 25% of newly diagnosed
breast cancers. There is debate about the benefit of sentinel lymph node biopsy (SLNB) for …
breast cancers. There is debate about the benefit of sentinel lymph node biopsy (SLNB) for …
Is sentinel lymph node biopsy necessary for ductal carcinoma in situ patients undergoing mastectomy?
JL Miller-Ocuin, M Howard-McNatt… - The American …, 2020 - journals.sagepub.com
Background Current treatment guidelines for ductal carcinoma in situ (DCIS) treated with
mastectomy recommend sentinel lymph node biopsy (SLNB). In the modern era, there is a …
mastectomy recommend sentinel lymph node biopsy (SLNB). In the modern era, there is a …
A randomized study comparing different doses of superparamagnetic iron oxide tracer for sentinel lymph node biopsy in breast cancer: the SUNRISE study
IT Rubio, R Rodriguez-Revuelto… - European Journal of …, 2020 - Elsevier
Introduction The non-radioactive method that uses the magnetic tracer (SPIO/Sienna) has
shown to be a feasible technique for the SLN detection in breast cancer patients. The aim of …
shown to be a feasible technique for the SLN detection in breast cancer patients. The aim of …
[HTML][HTML] Selective omission of sentinel lymph node biopsy in mastectomy for ductal carcinoma in situ: identifying eligible candidates
SJ Bae, Y Kook, JS Jang, SH Baek, S Moon… - Breast Cancer …, 2024 - Springer
Background Sentinel lymph node biopsy (SLNB) is recommended for patients with ductal
carcinoma in situ (DCIS) undergoing mastectomy, given the concerns regarding upstaging …
carcinoma in situ (DCIS) undergoing mastectomy, given the concerns regarding upstaging …
[HTML][HTML] The role of sentinel lymph node biopsy and factors associated with invasion in extensive DCIS of the breast treated by mastectomy: the Cinnamome …
C Tunon-de-Lara, MP Chauvet, MC Baranzelli… - Annals of Surgical …, 2015 - Springer
Background When invasive components are discovered at mastectomy for vacuum-assisted
biopsy (VAB)-diagnosed ductal carcinoma in situ (DCIS), the only option available is axillary …
biopsy (VAB)-diagnosed ductal carcinoma in situ (DCIS), the only option available is axillary …